The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system ...

A recent study revealed that mRNA COVID-19 vaccines, such as Pfizer and Moderna, may provide an amazing benefit for cancer ...

Results of new research showing that COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients and prolonged ...

Scientists have found that mRNA vaccines used to treat Covid-19 may prolong the lives of people with cancer who took them, ...

If mass vaccine deaths are imminent, it is not evident in the global life expectancy trends. Since the rollout of billions of ...

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers ...

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event – Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025. The ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin cancer who were ...

A study found that patients who took an mRNA vaccine along with immunotherapy for lung cancer or melanoma (a type of skin ...

BENGALURU: Yeast, an indispensable ingredient in making bread, beer, and biotech products, has the resilience to withstand ...

In the latest close session, Moderna (MRNA) was up +1.87% at $26.74. The stock outpaced the S&P 500's daily gain of 0.79%. Elsewhere, the Dow saw an upswing of 1.01%, while the tech-heavy Nasdaq ...